Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
This webinar is no longer available.
About This Webinar

Though there are thousands of rare diseases affecting more than 300 million people worldwide, only a small percentage of them have treatments. Considering this and the fact that over 50% of rare disease patients are children, the high unmet need for rare disease therapies has exponentially increased the number of drugs in development. Currently, according to Pharma projects, around 30% of all investigational products globally are in rare diseases, proving that rare disease drug development is moving higher up the pharma industry’s agenda.

Nevertheless, due to the myriad of challenges involved in rare disease drug development, it typically takes on average four years longer for rare disease medicines to successfully advance through clinical trials and on to FDA approval relative to non-rare disease medicines.

As a result, sponsors must be more strategic in their approach to rare disease drug development and leverage innovations and strategies to help them overcome these challenges to speed up development to bring much-needed treatments to patients. This webinar will explore these strategic considerations and innovations for accelerating the drug development of rare diseases. Our listeners will also understand the importance of patient- and site-centric solutions in aiding this process as well as gain insight into the Ergomed Rare Disease Innovation Center.

  • Rare Disease Overview and Market
  • Key Strategic Considerations for Rare & Orphan Drug Development
  • Innovations that Accelerate Rare Disease Drug Development
  • Patient and Site Centric Solutions
  • Ergomed Rare Disease Innovation Center
  • Q&A with Zizi Imatorbhebhe, MBA, MS, PMP®, Senior Vice President, Global Strategy & Development, Rare Disease, Ergomed
Language: English
Who can attend? Anyone with the event link can attend
Featured Presenters
Webinar hosting presenter
Senior Vice President, Global Strategy & Development, Rare Disease
Zizi is a seasoned executive with over 32+ years of drug development and commercial experience in the Bio-pharmaceutical, Clinical Research (CRO) and Healthcare industry. She has been instrumental in working collaboratively with many global sponsors especially in the Rare Disease space to identify drug development challenges for their programs and providing solutions to address them. She has also successfully commercialized over 25 pharmaceutical and medical device products globally. In addition, she works to leverage innovations to develop patient-oriented solutions and expand clinical trial access.
Webinar hosting presenter
Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed Clinical Research is a complete, global Phase I-IV clinical development and trial management service with a strong heritage in the development of drugs in rare diseases and oncology.
Hosted By
BioAlliance Video Network webinar platform hosts Strategic Considerations and Innovations that Successfully Impact Rare Disease Drug Development
BioAlliance Video Network's Webinars and Video Conferences